Response of Patients with Intermediate Beta-Thalassemia to Treatment with Hydroxyurea
Author(s):
Abstract:
Background
Hydroxyurea is a chemotherapeutic agent for treatment of cancer. This drug induces globin-g synthesis، so it could be used for treatment of thalassemia. Several studies have been shown that treatment with hydroxyurea increases Hb and HbF levels in patients with intermediate beta-thalassemia. However، the efficiency of hydroxyurea treatment in patients with beta-thalassemia is unclear. In the present study، clinical response of these patients to the drug was investigated. Methods
In this prospective study، the samples were patients with beta-thalassemia intermedia admitted to Sayed-al-Shohada hospital، Isfahan، Iran، during the years 2011-13. Efficiency of hydroxyurea in 46 patients was studied by determining the changes of Hb and HbF levels before and after one year of treatment with the drug. Treatment was performed using 500 mg capsule with dosage of 20 mg/day/kg. Patients were monitored for side effects، too. Findings
After treatment، the means of Hb and HbF levels increased at a rate of 0. 47 ± 1. 12 g/dl and 6. 04 ± 1. 43 percent، respectively; where the first was statistically significant، but the latter was not. Use of drug improved the quality of the patient''s condition and there was no side effect. Conclusion
According to our results، it is suggested that treatment with hydroxyurea could be effective in majority of patients with intermediate beta-thalassemia.Keywords:
Language:
Persian
Published:
Journal Of Isfahan Medical School, Volume:31 Issue: 264, 2014
Page:
39
magiran.com/p1227075
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یکساله به مبلغ 1,390,000ريال میتوانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
- حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران میشود.
- پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانههای چاپی و دیجیتال را به کاربر نمیدهد.
In order to view content subscription is required
Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!